MyAverix Finance
F · Healthcare
Oxurion NV (TG40)
Biotechnology
Oxurion NV (TG40) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TG40
P/E ratio
25.00
Oxurion NV (TG40) — FAQ
What is TG40's P/E ratio?
The price-to-earnings (P/E) ratio for Oxurion NV (TG40) is 25.00 (data as of 2026-05-21).
Does Oxurion NV pay a dividend?
Dividend yield is not available in the current snapshot for Oxurion NV (TG40). Check the MyAverix Finance app for the latest dividend data.
What sector is Oxurion NV in?
Oxurion NV (TG40) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TG40 listed on?
TG40 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.